FilingSEC EDGAR8-K
Atossa Therapeutics Releases Updated Corporate Presentation
· SEC accepted
StageN/A
Filing content
Atossa Therapeutics released an updated corporate presentation detailing the development status and future plans for its lead program, (Z)-Endoxifen.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…